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Abstract The purpose of medical autopsy has changed to
issues of quality assurance today. In addition, autopsies are
considered valuable in medical education, e.g., delivering
cases for problem-based learning for students. Many studies
underscore the need for autopsies also in the era of technical
progress emphasizing the continuing discrepancies between
antemortem and post mortem diagnoses. Despite these impor-
tant tasks, we face a decline of autopsy for several reasons
with complex interactions. The role of all persons involved
in this decline is evaluated and suggestions for changes are
proposed. Last but not least, the future of the autopsy is in the
hands of pathology itself.
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Introduction
“Dreams and realties” is the subtitle of this paper on the future
of the autopsy. With the strong decline of the autopsy in the
last decennia, it is a (last?) attempt to re-emphasize the impor-
tance of the autopsy in current medical practice. The dream of
some pathologists is a revival of the situation of the 1970–
1980s, when an autopsy was as a rule the final procedure
before a patient’s file was closed. Others are content with the
present situation since autopsies are “not their thing” anymore.
The reality is that the situation of the past will never return.
Why is this so complex? One element is current medical cur-
ricula, from which pathology as a discipline has largely dis-
appeared. Another is the spectacular improvement in modern
medicine’s spectrum of diagnostic capabilities. Yet another is
related to attitudes of attending physicians, of relatives of the
deceased, and of pathologists who perform and report the
autopsies. Recently many (usually more expensive) new au-
topsy approaches have been presented. It is unlikely that they
will be able to reverse the tide of the decline, as long as there is
no fundamental change in attitude towards autopsies, i.e., that
attending physicians and pathologist no longer being con-
vinced that autopsies are important as quality and teaching
instrument.
In this paper, history, documented value, and reasons for
the decline of the autopsy will be discussed, and suggestions
will be made to turn the situation around.
Short history of the autopsy
It is undeniable that the autopsy throughout history has been a
key procedure in understanding the pathologic basis of disease
and the cause of death of deceased patients. The first historical
manuscript on this subject, not based on incidental observa-
tions but on a thorough study of disease progression, was
written by Antonio Benivieni (1443–1502) and posthumously
published by his brother Geronimo in 1507 as De abditis
nonnullis ac mirandis morborum et sanationum causis (About
the hidden and incredible causes of diseases and cures) [1].
This was an outstanding achievement at that time, confirmed
by the fact that it lasted 170 years before the next book on this
topic was published. That book (1679) by Theophile Bonet
(1620–1689), Sepulchretum sive anatomia practica ex
cadaveribis morbo denatis (Burial vault/cemetery or anatom-
ical studies on bodies affected by disease) [2], was a
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compilation of nearly 3000 postmortem protocols written by
more than 450 authors from the Hippocratic literature up to
Bonet’s time. It provided further evidence in support of the
notion that diseases might have an anatomical substrate.
The eighteenth century was the beginning of a golden pe-
riod for the autopsy. The Dutch physician Herman Boerhaave
(1668–1732) was the author of two monographs in which
autopsies played a significant role. Both emphasized the im-
portance of a good clinical history [3]. The autopsy reported in
the first eventually led to recognition of the condition that is
known as the “Boerhaave syndrome.” The other described a
patient suffocating from a 3.5-kg mediastinal mass. These two
observations, however, were overshadowed some 50 years
later by Giovanni Morgagni’s De sedibus et causis morborum
per anatomen indignatis (About the seats and causes of dis-
eases investigated by anatomical investigations) in which he
described 640 autopsies, systematically correlating the symp-
toms of his patients with the pathological findings at autopsy
[4]. This was a breakthrough in the evolving concept that
diseases have an anatomical substrate.
The man who definitely should be regarded as the father of
the autopsy is the Austrian pathologist Carl von Rokitansky
(1804–1878). He was the first who looked at pathological
changes in human organs in a systematic manner. He carefully
correlated morphology with clinical symptoms in developing
the concept of pathogenesis. He was the first to take observa-
tions in Morgagni’s tradition to a higher level. This kind of
workmade him the best descriptive pathologist of his days [5].
In subsequent years, many pathologists paid increasing at-
tention to details of autopsy techniques and to standardization
of procedures, among them Virchow (1821–1902), who pub-
lished a booklet on autopsy techniques that became widely
used [6].
In the twentieth century, the autopsy flourished and laid a
solid basis for understanding the pathogenesis of disease. But
then from around 1970, the autopsy rate started to decline. The
decline persisted and autopsy percentages dropped from about
50 % of hospital deaths around 1960 to approximately 10 %,
and even less in some institutions, nowadays. Time will tell
whether, after a period of 150 years, the medical autopsy has
run its course as a useful method for investigating disease and
establishing cause of death, other than in a medicolegal
context.
The value of the autopsy in the early 21st century
One might expect that the decrease in autopsy number has
been at least partly due to decreasing enthusiasm among cli-
nicians for this last examination. However, in the last 15 years,
many papers were published that tell us otherwise. The num-
ber of papers, accumulated in PubMed in this period when
using as search term “autopsy,” amounts to over 28,000 and
for the two most recent years over 3800. Many of these papers
concern case reports in which autopsy findings are reported.
Research papers generally conclude that enough discrepancies
between clinical and anatomical findings persist to warrant the
performing of autopsies in the future. The discrepancies in the
papers are usually classified according to the Goldman criteria
[7]. A class I error is a major missed diagnosis, with potential-
ly adverse impact on survival, that would have changed man-
agement. A class II error represents a missed major diagnosis,
without potential impact on survival, that would not have
changed therapy. The class III and IVerrors are missed minor
diagnoses not related to the cause of the main disease(s).
A powerful paper in this regard is the meta-analysis of
Shojania et al. in JAMA in 2003 [8]. Their objective was to
determine the rate at which autopsies detect important, clini-
cally missed diagnoses and how this rate changed over time.
To achieve this goal, the authors performed a systematic liter-
ature search for relevant English papers published between
1966 and 2002 and available in Medline. They identified 45
studies reporting 53 distinct autopsy series. Of the 53 series,
42 reported major errors, of which 37 class I errors according
to the Goldman criteria. In 26 series, both major and class I
errors were found. The authors estimated that, while the error
rate had decreased, at the time of publication of their paper,
US institutions would probably observe a major error rate of
8.4 to 24.4 % with a class I error rate of 4.1 to 6.7 %.
Wittschreiber et al. reported on 1800 adult autopsies at one
single institution, the Charité Institute of Pathology in Berlin
[9]. Randomly selected cases of the years 1988, 1993, 1998,
2003, and 2008 were analyzed. Based on power analysis, the
rate of class I major discrepancies was 10.7 % in 2008,
representing a reduction of 15.1 % relative to 1988.
A study from India [10] described the discrepancies be-
tween antemortem and postmortem diagnoses in 591 patients
over the years 1947 to 2010 and concluded that the number of
discrepancies had decreased significantly over time, but that
the discrepancy rate in 2010 was still high at 9.3 %.
The same trend has been reported by several other groups
studying unselected autopsy cases [11–13]. In studies of se-
lected case series, the observed discrepancies tell a similar or
an even worse story. A meta-analysis [14], which only includ-
ed patients dying in an ICU in the period 1966 through 2011,
found 31 studies reporting on a total of 5863 autopsies. In this
study, in 28 % of the cases, at least one misdiagnosis was
noted, 8 % of class I and 18 % of class II “despite presumably
aggressive diagnostic assessment in the critical care environ-
ment.” They concluded “Our findings suggest that 34,000
ICU patients in the US may die as the result of a class I error
annually, assuming that the error was the cause of death.” A
Brazilian study [15] on critically ill patients with difficult an-
temortem diagnoses found in 50 % of 98 cases class I and
class II discrepancies, of which cardiovascular complications
were a main cause. An autopsy study in critically ill cancer
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patients in the ICU [16] found major discrepancies in 21 % of
cases, with aspergillosis, pulmonary embolism, and cancer
recurrence as the most commonly missed diagnoses. A study
among pediatric patients requiring extracorporeal membrane
oxygenator support found major discrepancies in 53 % of
cases, the most commonly missed diagnosis being myocardial
infarction found in 16 of 54 patients [17].
These and many other studies underscore the added value
of the autopsy even in our era of relentless technical progress.
We dare to postulate that the discrepancy rate between ante
mortem and postmortem findings will remain at about 10 %.
Autopsies as quality management tool
In the second half of the last century, the aspect “understand-
ing the pathogenesis of disease and detecting new disease
entities” has more or less faded into the background and sev-
eral authors emphasized the role of the autopsy as quality
assurance tool, focusing on the abovementioned differences
between antemortem and postmortem diagnoses. In addition,
autopsies continue to be considered valuable in medical edu-
cation, e.g., providing case material for problem-based learn-
ing. Autopsy cases would provide students the opportunity to
recall knowledge of anatomy and gain access to clinico-
pathological correlations. The latter might contribute to a basis
for quality management considerations.
The role of the autopsy in quality assurance concerns,
among others, evaluation of the accuracy of diagnostic imag-
ing, such as computerized tomography (CT), nuclear magnet-
ic resonance (NMR), and positron emission tomography
(PET) scans. Other fields of quality assurance are evaluation
of efficacy and potential adverse effects of new drugs, new
surgical techniques, and genetic engineering.
To this one might add activities in one way or the other
related to quality, such as
& Detection of new patterns in old diseases (e.g., tuberculo-
sis and syphilis)
& Providing information on disease course and cause of
death to next of kin of a deceased patients
& Facilitating investigation of environmental, occupational,
and lifestyle-related diseases
& Providing tissue for research
& Teaching medical students and residents in specialty
training
The role of the autopsy as a quality management tool has
focused on systematic analysis of discrepancies between clin-
ical (antemortem) and autopsy (postmortem) diagnoses, e.g.,
Rosen et al. [18], Pastores et al. [19], and Tavora et al. [20].
Zampieri et al. recently re-emphasized the clinico-
pathological conference, the quality of which often depends
on whether or not an autopsy has been performed, as a worth-
while argument in maintaining the autopsy [21].
While autopsies conceptually contribute to auditing of as-
pects of medical care, to the best of our knowledge, no studies
have shown that conducting autopsies and publicizing the
findings are directly beneficial for patients [22]. No data have
substantiated the notion that autopsy practice improves quality
of patient care. This implies that any beneficial effect, in terms
of quality assurance, of systematic performance of autopsies
on quality of care remains a matter of faith and remains to be
proven [23].
In spite of this lack of an evidence base, many clinicians
and pathologists have experienced the teaching effect of an
unexpected autopsy diagnosis, which may be beneficial for
many patients to come, however difficult this might be to
measure. Most commonly, autopsy reports reside in the ob-
scurity of pathology and medical records departments as or-
phan data, because they are not systematically evaluated [22].
Moreover, one has to bear in mind that the autopsy itself is
not error free since a pathologist, like any other physician, can
and will occasionally render an erroneous diagnosis. No stud-
ies have been performed to determine error rates in autopsy
diagnosis [24, 25]. In addition, a real danger exists for loss of
quality in autopsy practice, along with decreasing pathologist
experience in performing autopsies.
Reasons for autopsy decline
While many blame the demise of the autopsy on a low rate of
authorization by relatives or on a lack of interest of clinicians,
this issue is quite a bit more complex. A variety of economic,
social, medical, and technological factors are to be considered,
and it would be too simple to look for a single cause or even a
leading cause for this decline [26, 27]. Factors to be consid-
ered are as follows:
Medical curricula
The last decennia, many medical schools have changed their
curriculum from the classical discipline-based approach to an
integrated system-based program. This has resulted in frag-
mentation of pathology teaching over many integrated
courses, which tends to result in (much) fewer pathology con-
tact hours than before. Time and facilities for autopsy and
gross pathology demonstrations are often lacking. As a result,
many students arrive at the end of the classroom phase of their
medical studies without ever having attended an autopsy.With
the low actual autopsy rate, many of them will never have
attended an autopsy when they start their medical career. It
is not difficult to imagine that for those, the autopsy is not a
very relevant procedure and not the first issue to take care of
when a patient has died.
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Clinicians’ attitude
With undergraduate curricula that do not provide a favorable
climate for the autopsy, it cannot come as a surprise that many
clinicians are skeptical about the need for requesting an au-
topsy. That might also be the reason why they are skeptical in
regard of the reported levels of discrepancy between clinical
and autopsy diagnoses and hence do not perceive the autopsy
as an important procedure in clinical practice, despite the po-
sition of many professional organizations and learned socie-
ties and the wealth of evidence in support of the medical value
of the autopsy [28]. New sophisticated diagnostic procedures
have increased confidence in clinical diagnoses, resulting in
the opinion that the autopsy is outdated and longer needed.
Fear of litigation in case of a diagnostic error can exercise
restraint as well [29]. In addition, advanced age of a deceased
patient and the attitude of his or her relatives may negatively
influence a clinician’s decision whether or not to request an
autopsy. A reason frequently heard is the long turnaround time
of final autopsy reports, which may take weeks but often
months to be completed, to some extent depending upon the
motivation of the responsible pathologist [30].
Role of the pathologist
Many pathologists, in academic as in private practice, are
quite vocal about their own dislike of autopsies. Some just
do not like the procedure, which has been a reason for the
Royal College of Pathologists (UK) to offer a training track
for pathologists without developing any competency in autop-
sy practice. Others prefer alternative professional activities, in
view of better remuneration or academic recognition (e.g.,
publishing). New molecular findings in research and predic-
tive diagnostics offer more opportunities for publishing high-
impact papers and are more instrumental in developing a ca-
reer in academic pathology.
When asked, many pathologists will still provide lip ser-
vice to the importance of autopsies but fail to develop initia-
tives in their own hospital to increase the autopsy rate. On the
priority list, autopsies and autopsy reports end up at the bot-
tom. It will not come as a surprise that in many residency
training programs, the novice resident starts training with a
rotation in the autopsy room. And yet, the autopsy is the most
complex technical procedure of our discipline, requiring high-
level theoretical and practical anatomy and pathology knowl-
edge as well as a good level of understanding of histopathol-
ogy. Why then would this field of activity be preferentially
assigned to the least experienced members of staff? While
medical education has undergone important changes in the
last half century, training programs in pathology often still
blindly follow a tradition that has its roots back in the nine-
teenth century.
The confrontation with junior residents in the autopsy room
as a rule does not motivate the involved clinicians. In this
sense, it is revealing that autopsy pathology is not yet an
officially recognized subspecialty in pathology; worse even,
subspecialization is not even discussed presently, in spite of
the serious problems that are encountered. The declining au-
topsy rate is evidently not an issue of primary concern.
Financial reasons
Financial reasons are often stated as a reason for autopsy de-
cline and there is a lot of truth in this suggestion. A complex
autopsy case will include consulting a variety of specialists
and substantial reporting which might include a clinico-
pathological conference which will require many hours (may-
be even a full day) if the pathologist takes the case seriously.
Financial compensation usually falls short of what would be
gained by reporting surgical specimens in the same time
frame, which is in addition perceived as more convenient.
One reason for this unsatisfactory compensation is that for
hospital management, the honorarium for the pathologist is
but part of the total cost of an autopsy, which as a rule exceeds
a few thousand dollars/euros. Autopsy cost is often not reim-
bursed by health insurance companies as they tend to claim
that a deceased patient is not their client anymore. Adequate
funding for autopsies is likely to improve the interest for the
autopsy. [31].
Role of the family
The reasons most commonly cited by clinicians for the decline
in the autopsy rate include an increasingly onerous consent
process and the assumption that bereaved family members are
hostile to the idea of an autopsy. In a recent survey in Germa-
ny, about 50 % of people participating in the survey consid-
ered autopsy a necessary procedure and would allow their
own relatives to be autopsied. In a German study, many who
had recently experienced the death of a relative in a hospital
had not been asked permission for an autopsy [32]. In com-
municating with clinicians on the issue of authorization for
autopsy, the perceived percentage of refusal ranged from 50
to 90%. Close scrutiny suggested that many clinicians did not
request permission but up-front declared that the relatives de-
nied autopsy. The increasingly different ethnic backgrounds
and religious convictions in our increasingly multicultural so-
ciety contribute to the factual reasons for refusal of permission
for autopsy. An open question is whether or not the autopsy
permission rate would increase if relatives would be offered an
alternative non-invasive autopsy procedure. Moreover, pa-
tients often have the impression that they do the doctor a favor
by granting permission for an autopsy, rather than realizing
that it is their right to have this final consultation to confirm
that diagnoses and treatment were conducted lege artis.
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What follows from the situation described under “financial
reasons” is that relatives who would tend to insist on an au-
topsy on a deceased family member, for whichever reason,
might be confronted with a significant invoice from the hos-
pital, which can make them refrain from asking for an autopsy
or from pursuing their request. Our discipline should come up
with innovative approaches for funding an autopsy in situa-
tions in which payment by relatives is not reasonable.
New approaches to autopsy procedure
In view of the major objections of relatives against a classical
autopsy, alternative autopsy techniques have been conceived
which might overcome this problem. In the last decade, other
approaches to achieve this goal have been developed. A vari-
ety of imaging approaches, often combined with targeted bi-
opsies, have been published. To list a few, we can mention the
minimally invasive autopsy, the needle autopsy, the endoscop-
ic autopsy, the imaging autopsy, the verbal autopsy, the virtual
autopsy, and the partial autopsy [33–36]. An advantage of
minimally invasive procedures appears to be a better quality
of the obtained tissue samples relative to those taken during
the conventional autopsy, which constitutes an additional rea-
son to pursue these techniques [37].
These alternative autopsy techniques employing “clean”
and familiar imaging techniques (which can obtain adequate
samples for histological analysis) deserve a place in pathology
and might increase the number of autopsies performed in hos-
pitals. However, the success of this approach will again de-
pend strongly on the clinician’s conviction of the value of the
autopsy. Clinicians need to convince the relatives and this will
be less successful if the clinician himself lacks in conviction.
It is difficult to predict the cost of alternative autopsy pro-
cedures as this depends on a variety of factors. But even if the
nominal cost might be less, their introduction might increase
the overall cost of autopsy services. According to Thayyil,
“Although minimally invasive autopsy can be less expensive
than conventional autopsy, the overall cost of postmortem
services might rise because parents (relatives) who decide
against autopsy might want a minimally invasive autopsy,
which paradoxically increases the workload for both patholo-
gists and radiologists” [33].
Indications for performing an autopsy
Autopsies are important in quality management, teaching,
training, tissue collection for research (when permitted), death
statistics, etc. However, in this era, when autopsies seem to
almost vanish, an autopsy can be mandatory under certain
circumstances. A list of these indications, as published by
the German Pathology Society, might be of help [38]. This
list mostly stipulates medicolegal situations which are beyond
the subject of this paper. Many clinical situations strongly
calling for an autopsy are not listed.
The future of the autopsy in our hands
Autopsies have been on the decline in the past 50 years. It is
not realistic to think that we can turn this tide. Key concepts
regarding the pathogenesis of disease have come from autopsy
observations in the past. Practicing physicians rely on this
knowledge and may continue to learn from autopsies conduct-
ed on their own patients, which generates experience used in
daily practice. In addition, in spite of the wealth of new diag-
nostic laboratory and imaging techniques which often seem to
make an autopsy superfluous, errors are still made. Autopsy as
the “final consultation” before a patient file is closed remains a
valuable tool for self-evaluation of performance, and unex-
pected autopsy findings continue to provide life-long learning
moments. However, error rates have not gone up since the
autopsy rate started to decline and solid evidence that quality
of care has suffered does not exist.
There is no doubt that pathologist attitude towards autop-
sies has changed dramatically: lack of interest and perception
of an autopsy as a burden without significance or even as
inferior work. The position of the autopsy tends to be played
down when pathologists discuss what they do with outsiders.
Lack of interest results in delayed reports that often do not or
only partially provide relevant answers to the clinicians’ ques-
tions and some conclusions even end up to be wrong. Many
practicing pathologists lack sufficient up-to-date pathophysi-
ological knowledge and clinical orientation to adequately un-
derstand and answer the questions asked by clinicians. The
latter is a reflection of insufficient emphasis on understanding
mechanisms of disease (general pathology) in many training
programs, with their strong focus on diagnostic subspecialty
competences.
The decline of the autopsy rate is a reality, and with the
limited number performed, it is increasingly difficult to ac-
quire sufficient experience in performing, interpreting, and
reporting autopsies. It is essential that pathologists who per-
form autopsies are enthusiastic, interested, and competent and
respected for their knowledge in this field of our discipline.
Only these qualities will make them appreciated partners of
clinicians and good teachers of our residents. The only way to
achieve this goal is subspecialization in clinical autopsy pa-
thology, much like what has developed for forensic pathology
[39, 40]. Training in this subspecialty should include clinical
training in intensive care medicine, because ICU cases pro-
vide the most challenging questions. Knowledge of this field
will allow them to become real “sparring partners” for
intensivists, much like fetoplacental and neuropathologists
who are more readily accepted by their clinical colleagues as
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indispensable partners. Training autopsy pathologists for all
subspecialties would be an illusion, and, the ICU being the
ultimum refugium for patients of most disciplines, the clinical
autopsy pathologist will remain confronted with a wide range
of diseases.
The creation of autopsy pathology as a subspecialty might
also solve the issue of late and insufficient reporting. The
subspecialist will develop and introduce new autopsy tech-
niques and will develop initiatives to change the attitude to-
wards autopsies in the clinics. If we bring our best human
capital to the frontline and respect these professionals as high-
ly as any other subspecialist, the tide may change, but only if
we really want to.
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